D-0734-2026 Class II Ongoing
FDA drug recall D-0734-2026 was initiated by MYLAN PHARMACEUTICALS INC on Jul 2, 2026 and is designated Class II. Reason for recall: Presence of precipitate The recall status is ongoing. Affected quantity: 5688 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 5, 2026
- Initiation Date
- Jul 2, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5688 vials
Product description
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
Reason for recall
Presence of precipitate
Distribution pattern
USA Nationwide
Code information
Lot #: 3241653, Exp 4/30/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0734-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026